A heptapeptide formed from ANGIOTENSIN II after the removal of an amino acid at the N-terminal by AMINOPEPTIDASE A. Angiotensin III has the same efficacy as ANGIOTENSIN II in promoting ALDOSTERONE secretion and modifying renal blood flow, but less vasopressor activity (about 40%).
Angiotensin Iii has been studied across 19 research domains including ❤️ Cardiovascular, 🫘 Kidney, 🧠 Focus & Attention, 🔬 Inflammation, 🏋️ Muscle & Hypertrophy. The primary research focus is ❤️ Cardiovascular with 39% of studies addressing this area.
This evidence profile for Angiotensin Iii is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.